News
California-backed cure for ‘bubble baby’ disease stalls — again
A pipette drops stem cell research fluid on a special container. (Photo: CI Photos, via Shutterstock) The “bubble babies” saga and a California-financed cure for their life-threatening affliction has hit another snag, more than two years after a British company abandoned the effort. It is a story that involves more than $40 million from California’s stem cell agency, federal regulators, the University of California, the agonizingly slow pace of science and 20 children who have been denied care — not to mention a company called Orchard Therapeutics PLC.
